Missing: iBOLT's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: iBOLT's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest iBOLT News
Jan 17, 2012
(You can enter multiple email addresses separated by commas) Message : *Required fields In 2005, Stallergenes used iBOLT to build an online prescription tracking service that streamlined its back-office information flows. Following this successful implementation, Stallergenes has now launched a new project, once again using Magic's technology, to . iBOLT linked Stallergenes' disparate systems, enabling them to automatically convert purchase orders and entries from its Lawson M3 ERP, hosted on an AS/400 server (), before integrating them into the company's . "iBOLT serves as the communication hub for our various applications. It is our 'orchestra conductor', communicating natively with our various systems," comments Thierry Gréhaigne, CIO of Stallergenes. "It has enabled us to optimize our workflows, making them reliable and completely transparent for users, whether they are at our French, German, or Italian site. " has enabled us to implement a high-performance, paperless infrastructure," he adds. "Because it has always been able to safeguard existing systems, we can look ahead to future technological changes with confidence. " "We are very pleased that Stallergenes has once again chosen Magic Software's products," said Guy Bernstein, CEO of Magic Software. " has again proven its ease-of-use and ability to deliver rapid time-to-market integration solutions. " About Magic Software Magic Software Enterprises Ltd. (NASDAQ: MGIC), is a global provider of mobile and cloud-enabled application and business integration platforms. About Stallergenes Stallergenes is a European biopharmaceutical company that focuses on allergenic immunotherapy to treat allergic respiratory illnesses, such as rhinoconjunctivitis, severe rhinitis, and allergic asthma. A pioneer and leader in sublingual immunotherapy, Stallergenes ploughs more than 20% of its revenue back into R&D, and seeks to develop a new therapeutic classification: sublingual immunotherapy tablets. In 2010, over 500,000 patients were treated with Stallergenes products. React to this article Latest news on MAGIC SOFTWARE ENTERPRISES 03/30
iBOLT Frequently Asked Questions (FAQ)
Where is iBOLT's headquarters?
iBOLT's headquarters is located at 11 Flower Street, Arcadia.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.